The
global microcarriers market size is expected to reach USD
3.71 billion by 2030, registering a CAGR of 11.53% from 2024 to 2030, according
to a new report by Grand View Research, Inc. The market is expected to
expand at a CAGR of 11.6% from 2022 to 2030. The growth of the market is driven
by the rising demand of cell-cultured products, the growing burden of diseases
worldwide, constant investments for intensive R&D activities to identify
and develop new treatments for rare disorders, and the continuous developments
in technologies employed in advanced research such as cell-biology.4
Amidst
the COVID-19 pandemic, the market witnessed a positive growth. The continuous
strive of scientist and researchers to find and develop vaccines for the
SARS-CoV2 virus resulted in scaling up of R&D efforts by both healthcare
companies and academic institutes. The increased research activities, huge
funding, and growing demand of therapeutic products resulted in the growth of
the market. Moreover, development of viral vectors based vaccines requires
efficient production of viruses which is possible using microcarriers
cell-culture. For instance, scientists from University of Copenhagen
demonstrated in their research article published in June 2021 that SARS-CoV2
virus was efficiently produced in Vero cells in a single-use bioreactors packed
with carrier beads. Findings like these have boosted the COVID-19 vaccine
production further propelling market growth.
Moreover,
the marketspace is rapidly expanding owing to the high usage of microcarriers
as matrix for adherent cell manufacturing and these small spherical beads are
used across all scales of commercial production. The increasing demand of
innovative therapeutic options such as cell and gene therapy, viral vaccines,
and monoclonal antibodies for treatment of malignant and rare diseases has
resulted in increase in the biopharmaceutical production capacities. For
example, Pfizer Inc., announced in December 2021 that it has invested USD 68.5
million and opened a new facility in North Carolina, USA. With the expansion
the company is focused on enhancing its gene therapy capabilities and
clinically develops its portfolio for hemophilia A and B, DMD (Duchenne
muscular dystrophy), ALS (amyotrophic lateral sclerosis) and many more neurologic,
endocrine as well as metabolic diseases. Such increased investments for
development of biopharmaceuticals and regenerative medicines are expected to
propel the market growth.
Furthermore,
cell-biology based research involves exhaustive R&D for developing new
therapies. But these efforts require investments for cell lines, media,
equipment and other related products for microcarriers culture and thus
requires huge influx of money. Institutes and emerging players with budget
constraints will limit the cell based research for therapeutics development.
Hence, it will decrease the adoption of cell-culture products and restrain the
growth. However, government initiatives for novel drug production and
collaboration & partnerships with key players can offer investment relief
and enhance the market growth.
List
of Key Players in the Microcarriers Market
- Thermo Fisher
Scientific, Inc.
- Merck KGaA
- Danaher
Corporation
- Sartorius AG
- Corning
Incorporated
- Eppendorf SE
- Bio-Rad
Laboratories, Inc.
- HiMedia
Laboratories Pvt. Ltd.
- denovoMATRIX
GmbH
Request
a free sample copy or view report summary: Microcarriers Market Report
Microcarriers
Market Report Highlights
- By
consumables, the microcarrier beads was identified as the largest contributor
with a 70.1% share of the market in 2023. Presence of key players offering
the products along with their continuous usage during bio-manufacturing
process drives market growth
- By
application, the biopharmaceutical production segment is anticipated to
grow significantly over the forecast period. Increased demand for vaccine
during the COVID-19 pandemic and continuous regulatory support for
therapeutics boosts the usage of microcarriers during bio-manufacturing,
leading to highest segment share
- The contract
research organizations (CROs) & contract manufacturing organizations
(CMOs) segment captured the largest market share at 40.3% in 2023. The
increasing demand for outsourcing services in the pharmaceutical and
biotechnology industries drives this segment.
- North America
generated the highest revenue with a 36.7% share in 2023. The major
factors for the regional dominance are prevalence of diseases, presence of
key market players, high usage of cell based products, and supportive
government initiatives
- Asia Pacific
region will witness the fastest growth in the microcarriers market during
the forecast, due to rising R&D activities, increased domestic demand
of biologics and growing economies
Microcarriers Market Report Scope
|
Report Attribute |
Details |
|
Market size value in 2024 |
USD 1.93 billion |
|
Revenue forecast in 2030 |
USD 3.71 billion |
|
Growth rate |
CAGR of 11.53% from 2024 to 2030 |
|
Base year for estimation |
2023 |
|
Historical data |
2018 - 2022 |
|
Forecast period |
2024 - 2030 |
Microcarriers
Market Segmentation
Grand
View Research has segmented the global microcarriers market on the basis of on
consumable, application, end-use and region:
Microcarriers
Consumable Outlook (Revenue, USD Million, 2018 - 2030)
- Media &
Reagents
- Microcarrier
Beads
Microcarriers
Application Outlook (Revenue, USD Million, 2018 - 2030)
- Biopharmaceutical
Production
- Regenerative
Medicine
Microcarriers
End-use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical
& Biotechnology Companies
- Contract
Research Organizations & Contract Manufacturing Organizations
- Academic
& Research Institutes
Microcarriers
Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East
and Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Explore Horizon, the world's most expansive market
research database
About Us:
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The company
provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment